Diuretics, HR, Antidysrhythmic Flashcards
(81 cards)
1
Q
Thiazide Diuretics
A
hydrochlorothiazide (HCTZ)
-K+ wasting
2
Q
Hyrdrochlorothiazide (HCTZ)
MOA
A
Inhibits resorption of Na+, K+, & Cl: results in osmotic water loss
3
Q
Hyrdrochlorothiazide (HCTZ) Indications
thiazide diuretic
A
Edema Adjuncts in treatment in HF Diabetes insipidus Hypertension Idiopathic hypercalciuria (excess CA+ in urine)
4
Q
Hyrdrochlorothiazide (HCTZ) Contraindications
Thiazide diuretic
A
Allergy Hepatic coma Anuria Severe renal failure (These patients already have electrolyte imbalances)
5
Q
Hyrdrochlorothiazide (HCTZ) AE’s
A
Related to electrolyte & metabolic disturbances they cause: Hypokalemia Hypercalcemia Hyperglycemia Elevated lipids Uric acid levels Hyponatremia? Dehydration
6
Q
Hyrdrochlorothiazide (HCTZ) Interactions
A
Corticosteroids
Digoxin
Oral hypoglycemic drugs
7
Q
Potassium-Sparing Diuretics
A
Spironolactone (Aldactone)
8
Q
Spironolactone (Aldactone) MOA
A
Interfere with sodium-potassium exchange
works in the collecting ducts & distal convoluted tubules
9
Q
Spironolactone (Aldactone) Indications
K+-sparing diuretic
A
- Hyperaldosteronism
- Hypertension
- Hypokalemia caused by K+-wasting diuretics
- HF in Pediatric patients
10
Q
Spironolactone (Aldactone) Contraindications
A
- Hyperkalemia
- Severe renal failure
- Anuria
- Allergy
11
Q
Spironolactone (Aldactone) AE’s
K+-sparing diuretic
A
- Gynecomastia (male swollen breast tissue
- Amenorrhea (absence of period)
- Irregular menses
- Postmenopausal bleeding
- Hyperkalemia
- Dizziness
- HA
12
Q
Spironolactone (Aldactone) Interactions
K+-sparing diuretic
A
- ACE inhibitors
- Lithium (increased lithium)
- NSAIDs (more bleeding)
13
Q
Loop Diuretics
A
furosemide (Lasix)
14
Q
furosemide (Lasix) MOA
A
Block chloride & Na+ resorption
Renal, cardiovascular & metabolic effects
15
Q
furosemide (Lasix) Indications
A
- Edema
- HF
- hepatic & renal disease
- Hypertension
- Hypercalcemia
16
Q
furosemide (Lasix) Contraindications
Loop diuretic
A
- Hepatic coma
- Severe electrolyte loss
- Allergy
17
Q
furosemide (Lasix) AE’s
A
- Hypokalemia
- Photosensivity
- Dizziness
- HA
18
Q
furosemide (Lasix) Interactions
A
- NSAIDs
- vancomycin
- corticosteroids
- digoxin
- lithium
- aminoglycoside antibiotics
19
Q
Toxicity & overdose of hydrochlorothiazide & furosemide (Lasix)
A
K+ wasting =hypokalemia:
- alkalosis
- shallow respirations
- irritability
- confusion
- weakness
- arrhythmias
- lethargy
- thready pulse
- decreased intestinal motility
20
Q
Toxicity & overdose of spironolactone (aldactone)
A
K+-sparing = hyperkalemia:
- muscle twitches, cramps, paresthesia
- Irritability & anxiety
- Decreased BP
- EKG changes
- Dysrhythmias
- Abdominal cramping
- Diarrhea
21
Q
Heart Failure drugs
A
- Cardiac Glycosides: (digoxin)
2. Phosphodiesterase inhibitors (Milrinone)
22
Q
Older Adults & Diuretics
A
Effects of diuretics are typically more exaggerated in older adults
Start with lower doses and gradually increase
Monitor for s/s of hyperkalemia, hypokalemia, dehydration
Change positions slowly
Have alternate methods for urination available (i.e. bedside commode, urinal)
23
Q
Drug classes for Heart Failure
A
- Angiotensin-converting enzyme inhibitors (ACE) inhibitors
- Angiotensin receptor blockers (ARBs)
- Beta blockers
- Loop diuretics
- Remember, cardiac glycosides (i.e. digoxin) are used last!
24
Q
Inotropic Drugs
A
Force of contraction
- (Positive) Increase force of myocardial contraction
- (Negative) Reduce force of contraction
25
Chronotropic Drugs
Heart Rate
- (Positive) increase HR
- (Negative) decrease HR
26
Dromotropic Drugs
Conduction
- (Positive) accelerate conduction
- (Negative) slow down conduction
27
Cardiac Glycoside
digoxin (Lanoxin)
28
digoxin (Lanoxin) MOA
Positive inotropic effect (increase force of contraction)
Negative chronotropic effect (Decreased HR)
Negative dromotropic effect (decreased conduction)
29
digoxin (Lanoxin) Indications
systolic HF
| atrial fibrillation
30
digoxin (Lanoxin) Contraindications
- 2nd/3rd degree heart block
- ventricular tachycardia & fibrillation
- diastolic HF
- subaortic astenosis
- Allergy
31
digoxin (Lanoxin) AE's
- bradycardia or tachycardia
- hypotension
- HA
- fatigue
- confusion
- convulsions
- colored vision, halo vision
- anorexia
- N/V/D
32
digoxin (Lanoxin) Interactions
-Amiodarone
-quinidine
-verapamil
These drugs increase digoxin levels by 50%!
33
Digoxin normal therapeutic levels
0. 5-2 mg/mL
| - Low K+/Mg levels may increase potential for digoxin toxicity
34
digoxin (Lanoxin) Toxicity S/S
- bradycardia
- HA
- Dizziness
- Confusion
- Nausea
- Visual disturbances (blurred or yellow)
35
digoxin (Lanoxin) Antidote
digoxin immune Fab
36
Who is at increased risk of digoxin toxicity?
1. Older adults
| 2. Hypokalemia
37
digoxin (Lanoxin) toxicity management
1. Discontinue drug
2. Begin ECG monitoring -give antidysrhythmic meds as ordered
3. Determine serum digoxin & electrolyte levels
4. Administer K+ supplements for hypokalemia
5. Institute supportive therapy for GI symptoms
6. Administer digoxin immune Fab
38
Phosphodiesterase inhibitors:
Milrinone (Primacor)
39
Milrinone (Primacor) MOA
```
Positive inotropic (increases force of contraction)
Causes vasodilation
```
40
Milrinone (Primacor) Indications
used in intensive care setting for short-term management of acute HF
41
Milrinone (Primacor) contraindications
- severe aortic or pulmonary vascular disease
- HF caused by diastolic dysfunction
- Allergy
42
Milrinone (Primacor) AE's
- Ventricular dysrhythmias occur in 12%
- Hypotension
- Angina
- Hypokalemia
- tremor
- Thrombocytopenia
43
Milrinone (Primacor) interactions
- diuretics-may cause hypovolemia & reduced cardiac filling pressure
- Additive inotropic effects when also taking digoxin
44
Milrinone (Primacor) Nursing Considerations
- Most often used in ICU setting for acutely ill HF
- Monitor tele for ventr. dysr
- IV Pump
- Do not give in same line IV line as other drugs
45
Antidysrhythmic:
| Class 1A Sodium channel blockers
quinidine (Quinide)
46
quinidine (Quinide) MOA
Blocks entry of Na+ into cardiac cells causing slower impulse conduction, decreased automaticity of ventricles & longer resting period
47
quinidine (Quinide) Indications
Atrial Fibrillations
| Atrial Flutter
48
quinidine (Quinide) Contarindications
- Severe heart block
- Severe HF
- Asthma
- Myasthenia gravis
- low WBCs
49
quinidine (Quinide) AE's
- GI
- Hypotension
- Ventricular dysrhythmia (toxicity)
- Arterial embolism
- cinchonism (tinnitus, visual disturbances, HA, N/V)
50
quinidine (Quinide) Interactions
- Anticholinergics
- Antidysrhymics
- Cholinergics
- Antihypertensives
- Digoxin
- Grapefruit
51
Antidysrhythmic Drugs
1. quinidine (Quinidex) 1A Sodium channel blocker
2. Flecainide (Tambacor) 1C sodium channel blocker
3. amiodarone (Cordarone, Pacerone) 3 potassium channel blocker
4. verapamil (Calan) IV Calcium Channel Blocker
5. adenosine (Adenocard) unclassified
52
quinidine Interventions
1. Monitor HR, BP, GI symptoms
2. Keep patient supine during IV therapy (ortho hypo)
3. Monitor ECG
4. Monitor blood levels for toxicity
5. Use an IV pump for
6. Monitor & report s/s of cinhonism
53
flecainide (Tambocor) MOA
| Sodium channel blocker
Blocks entry of Na+ into cardiac cells
54
flecainide (Tambocor) Indications
- Serious supraventricular & ventricular tachydysrhythmias not controlled by other drugs
- Used long-term for some supraventricular dysrhythmias
55
flecainide (Tambocor) Contraindications
1. 2nd/3rd degree AV block
2. Prolonged QT interval
3. Recent MI
4. Shock
5. Electrolyte Imbalance
56
flecainide (Tambocor) AEs
1. Blurry vision (difficulty focusing)
2. Worsening of HF
3. Edema
4. Widening of QRS complex
5. Potential for 1st degree AV block & multiple dysrhythmias
57
flecainide (Tambocor) Interactions
1. Digoxin
2. beta blockers
3. Calcium channel blockers
58
flecainide (Tambocor) Interventions
1. Monitor for & report visual changes
2. Monitor for crackles in lungs, edema, weight gain
3. Monitor ECG
4. Monitor blood levels to detect toxicity
5. Oral use only!
6. Begin w. lowest dose & gradually increase no more than every 4 days
59
amiodarone (cordarone, pacerone)
| Potassium channel blocker MOA
Block K+ channels, decrease automaticity, decrease contractility, & dilates coronary and peripheral vessels
Widens QRS complex, prolongs both PR & QT intervals
60
amiodarone (cordarone, pacerone) Indications
Manage life-threatening ventricular tachycardia or fibrillation that is resistant to other drugs
Treats Atrial fib
61
amiodarone (cordarone, pacerone) Contraindications
- Pregnancy
- Lactation
- Shock
- Bradycardia
- Heart block
- sinus node dysfunction
- Severe hepatic disease
- Allergy
62
amiodarone (cordarone, pacerone) AEs
1. GI
2. Pulmonary toxicity (lungs become fibrous)
3. visual
4. cardiac
5. blue-grey discoloration of skin
6. CNS
63
amiodarone (cordarone, pacerone) Interventions
1. Monitor & report GI
2. Baseline & periodic chest x-ray & pulmonary function tests
3. Auscultate breath sounds & report changes
4. Monitor changes in vision or light sensitivity
5. Monitor HR & BP
6. Watch cardiac rhythm constantly during IV infusion
7. Monitor for wt. changes, edema, skin discoloration, CNS effects
8. Oral & IV
64
verapamil (Calan)
| Calcium channel blockers MOA
Block calcium channel blockers in the myocardium, prolongs PR interval
65
verapamil (Calan)
| Calcium channel blockers Indications
1. convert supraventricular tachycardia to regular sinus rhythm,
2. slow rate of atrial fibrillation & flutter
66
verapamil (Calan)
| Calcium channel blockers Contraindications
- Sever hypotension
- Cardiogenic shock
- Liver or kidney dysfunction
67
verapamil (Calan)
| Calcium channel blockers AEs
- Hypotension
- Bradycardia
- HF
- Peripheral edema of feet & legs
- Lightheadedness
- Dizziness
68
verapamil (Calan)
| Calcium channel blockers Interactions
Antihypertensive
Lithium
Grapefruit juice
69
verapamil (Calan)
| Calcium channel blockers intervetnions
1. Monitor VS & cardiac rhythm w/ IV meds. (keep patient supine for 1 hour)
2. Monitor BP
3. Withhold dose and notify provider for: BP lower 90 & pulse slower than 60
4. Monitor for & report edema, low urine output, crackles in lungs & lightheadedness
5. Oral & IV
6. Give PO dose with food
70
unclassified antidysrhythmic
adensosine (Adenocard)
71
adensosine (Adenocard)
unclassified antidysrhythmic
MOA
slows conduction through AV node, very short half life (less than 10 secs!)
72
adensosine (Adenocard)
unclassified antidysrhythmic
Indications
convert PSVT to sinus thythm
73
adensosine (Adenocard)
unclassified antidysrhythmic
Contraindications
- 2nd/3rd degree heart block
- sick sinus sundrome
- Allergy
74
adensosine (Adenocard)
unclassified antidysrhythmic
AEs
- commonly causes asystole for a period of seconds
| - all other AEs are minimal due to short half-life
75
adensosine (Adenocard)
unclassified antidysrhythmic
Interactions
Rare b/c of short half life
76
Contradictions/Cautions for ALL Antidysrhythmics
- allergy
- 2nd/3rd degree AV block
- bundle branch block
- cardiogenic shock
- sick sinus syndrome
- any other ECG changes depending on clinical judgement of cardiologist
- other antidysrhythmic drugs
77
AEs of ALL antidysrhythmics
- Dysrhythmias
- Hypersensitivity reactions
- N/V/D
- dizziness
- HA
- Blurred vision
- Prolongation of QT interval
78
Antidysrhythmic Nursing implications
- Thorough drug & medical history
- Baseline BP, HR, I/O, cardiac rhythm
- Serum K+ levels before starting
- Contraindications (specific drugs)
- Potential drug interactions
79
Antidysrhythmic Nursing implications
| During therapy
- Monitor cardiac rhythm, HR, BP, general well-being, skin color, Temp., heart & lung sounds
- Assess plasma drug levels
- Monitor for AE & toxic effects
80
Antidysrhythmic Education
-Take meds as scheduled
-Do NOT skip doses or double up for missed doeses
-Do NOT crush or chew oral sustained release
Notify:
-SOB
-Edema
-Dizziness
-Syncope
-Chest pain
-GI distress
- Blurred vision
-
81
Antidysrhythmic Nursing Evaluations
This is what we want to see:
- Decreased BP
- Decreased edema
- Decreased fatigue
- Regular HR
- Improved regularity or rhythm
- Improved cardiac output
